▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1104 by analyst upside · 2026-09-28
SRTA
Strata Critical Medical, Inc.
Healthcare · Market Cap $472M · P/E 0x
ANALYST PRICE TARGET
+79.4%
implied upside to consensus target
Current Price $5.33
Consensus Target $9.56
Bull Target $12.75
Bear Target $8.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
4
Hold
0
Sell
0
52-Week Low $3.95
52-Week High $6.5
YTD Return +8.1%
FUNDAMENTALS
Market Cap $472M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.28
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $256M
Profit Margin 15.7%
52-WEEK RANGE
52-Week Low $3.95
52-Week High $6.5
Current Price $5.33
Bear Target $8.0
Bull Target $12.75
● Now $5.33 ● Target $9.56
TRADING DATA
Avg Volume 979K
YTD Return +8.1%
Analyst Count 4
Consensus Buy
Upside to Target +79.4%
Last Updated 2026-09-28

ANALYST SUMMARY

Strata Critical Medical, Inc. (SRTA) is currently trading at $5.33 with a Wall Street consensus price target of $9.56, implying potential upside of 79.4% over the next 12 months. 4 analysts currently cover SRTA, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $12.75, while the most cautious has a target of $8.0.

SRTA operates in the Healthcare sector with a market capitalisation of $472M. The stock is up 8.1% year-to-date and is currently trading near the upper end of its 52-week range of $3.95 – $6.5.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CRMD +95.3%
CorMedix Inc.
$612M · P/E 3.6x · Strong Buy
TCMD +71.6%
Tactile Systems Technology, Inc.
$515M · P/E 20.9x · Buy
ASMB +119.7%
Assembly Biosciences, Inc.
$482M · P/E 19.1x · Buy
KMDA +54.8%
Kamada Ltd.
$503M · P/E 22.9x · Buy
IRWD +47.7%
Ironwood Pharmaceuticals, Inc.
$682M · P/E 5.2x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for SRTA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Craig-Hallum ● Initiated
Buy 2026-03-25 Building track record
B. Riley Securities ● Initiated
Buy 2026-03-25 17% win rate (6 calls)
Lake Street - Reiterated
Buy → Buy 2025-09-17 27% win rate (11 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
51
out of 100
Coverage depth
12/30
Consensus clarity
12/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →